| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 3/25/2025 | OPT Opthea | Downgrade | $3.00 | $12.00 ➝ $1.00 | Outperform ➝ Market Perform | Low |
| 3/24/2025 | LXEO Lexeo Therapeutics | Lower Price Target | $4.00 | $19.00 ➝ $18.00 | Outperform ➝ Outperform | High |
| 3/24/2025 | MEDP Medpace | Initiated Coverage | $319.00 | $330.00 | Market Perform | Low |
| 3/21/2025 | ELEV Elevation Oncology | Downgrade | $0.00 | $9.00 ➝ $1.00 | Outperform ➝ Market Perform | High |
| 3/17/2025 | STTK Shattuck Labs | Initiated Coverage | $1.00 | $4.00 | Outperform | High |
| 3/17/2025 | NRIX Nurix Therapeutics | Initiated Coverage | $12.00 | $16.00 | Market Perform | Medium |
| 3/11/2025 | TSVT 2seventy bio | Reiterated Rating | $5.00 | $9.00 ➝ $5.00 | Outperform ➝ Market Perform | High |
| 3/10/2025 | TENX Tenax Therapeutics | Set Price Target | $6.00 | $20.00 | | Low |
| 3/7/2025 | XERS Xeris Biopharma | Boost Price Target | $6.00 | $5.00 ➝ $6.00 | Outperform ➝ Outperform | High |
| 3/7/2025 | CRMD CorMedix | Initiated Coverage | $7.00 | $18.00 | Outperform | High |
| 3/4/2025 | LXRX Lexicon Pharmaceuticals | Reiterated Rating | $0.00 | $2.00 ➝ $1.00 | Outperform ➝ Market Perform | Medium |
| 3/3/2025 | PLRX Pliant Therapeutics | Downgrade | $1.00 | $33.00 ➝ $2.00 | Outperform ➝ Market Perform | High |
| 2/28/2025 | RXRX Recursion Pharmaceuticals | Lower Price Target | $6.00 | $7.00 ➝ $6.00 | Market Perform ➝ Market Perform | Low |
| 2/25/2025 | MAZE Maze Therapeutics | Initiated Coverage | $11.00 | $28.00 | Outperform | High |
| 2/25/2025 | HIMS Hims & Hers Health | Boost Price Target | $34.00 | $24.00 ➝ $40.00 | Market Perform ➝ Market Perform | High |
| 2/24/2025 | BBNX Beta Bionics | Initiated Coverage | $13.00 | $28.00 | Outperform | Low |
| 2/18/2025 | ATYR Atyr PHARMA | Initiated Coverage | $3.00 | $16.00 | Outperform | High |
| 2/13/2025 | MGM MGM Resorts International | Downgrade | $32.00 | | Market Perform | N/A |
| 2/13/2025 | TXG 10x Genomics | Downgrade | $9.00 | $25.00 ➝ $12.00 | Outperform ➝ Market Perform | High |
| 2/13/2025 | GMAB Genmab A/S | Upgrade | $20.00 | $27.00 | Market Perform ➝ Outperform | High |
| 2/13/2025 | CVS CVS Health | Upgrade | $67.00 | $55.00 ➝ $75.00 | Market Perform ➝ Outperform | High |
| 2/11/2025 | CVS CVS Health | Boost Price Target | $67.00 | $51.00 ➝ $55.00 | Market Perform ➝ Market Perform | High |
| 2/10/2025 | AXSM Axsome Therapeutics | Boost Price Target | $118.00 | $110.00 ➝ $150.00 | Outperform ➝ Outperform | High |
| 2/7/2025 | DOCS Doximity | Upgrade | $63.00 | $60.00 ➝ $90.00 | Market Perform ➝ Outperform | High |
| 2/6/2025 | HOLX Hologic | Downgrade | $61.00 | $80.00 ➝ $75.00 | Outperform ➝ Market Perform | High |
| 2/5/2025 | REGN Regeneron Pharmaceuticals | Upgrade | $634.00 | $762.00 ➝ $834.00 | Market Perform ➝ Outperform | High |
| 2/4/2025 | REGN Regeneron Pharmaceuticals | Lower Price Target | $634.00 | $980.00 ➝ $862.00 | Market Perform ➝ Market Perform | Low |
| 1/27/2025 | ISRG Intuitive Surgical | Boost Price Target | $510.00 | $490.00 ➝ $548.00 | | Low |
| 1/23/2025 | JNJ Johnson & Johnson | Lower Price Target | $162.00 | $182.00 ➝ $169.00 | Outperform ➝ Outperform | Low |
| 1/17/2025 | LLY Eli Lilly and Company | Set Price Target | $835.00 | $950.00 | | Low |
| 1/16/2025 | MRNA Moderna | Lower Price Target | $32.00 | $31.00 ➝ $27.00 | Underweight ➝ Underweight | Low |
| 1/13/2025 | FDMT 4D Molecular Therapeutics | Lower Price Target | $4.00 | $31.00 ➝ $27.00 | Outperform ➝ Outperform | High |
| 1/13/2025 | VIR Vir Biotechnology | Boost Price Target | $7.00 | $18.00 ➝ $20.00 | Outperform ➝ Outperform | Medium |
| 1/13/2025 | SPRY ARS Pharmaceuticals | Boost Price Target | $13.00 | $26.00 ➝ $27.00 | Outperform ➝ Outperform | High |
| 1/13/2025 | MRK Merck & Co., Inc. | Lower Price Target | $88.00 | $136.00 ➝ $119.00 | Outperform ➝ Outperform | Low |
| 1/8/2025 | ACCD Accolade | Reiterated Rating | $7.00 | | Outperform ➝ Market Perform | N/A |
| 1/6/2025 | DGX Quest Diagnostics | Upgrade | $167.00 | $169.00 ➝ $174.00 | Market Perform ➝ Outperform | N/A |
| 1/6/2025 | ALGN Align Technology | Upgrade | $165.00 | $235.00 ➝ $280.00 | Market Perform ➝ Outperform | N/A |
| 12/27/2024 | KYMR Kymera Therapeutics | Reiterated Rating | $30.00 | $60.00 ➝ $60.00 | Outperform ➝ Outperform | N/A |
| 12/12/2024 | LVTX LAVA Therapeutics | Reiterated Rating | $1.00 | $11.00 ➝ $2.00 | Outperform ➝ Market Perform | N/A |
| 12/11/2024 | QURE uniQure | Boost Price Target | $14.00 | $26.00 ➝ $44.00 | Outperform ➝ Outperform | N/A |
| 12/11/2024 | QTTB Q32 Bio | Reiterated Rating | $2.00 | $68.00 ➝ $9.00 | Outperform ➝ Market Perform | N/A |
| 12/11/2024 | PDCO Patterson Companies | Reiterated Rating | $31.00 | $29.00 ➝ $31.35 | Outperform ➝ Market Perform | N/A |
| 12/11/2024 | ANIP ANI Pharmaceuticals | Initiated Coverage | $67.00 | $80.00 | Outperform | N/A |
| 12/9/2024 | MYGN Myriad Genetics | Downgrade | $9.00 | $30.00 ➝ $21.00 | Outperform ➝ Market Perform | N/A |
| 12/5/2024 | OKUR OnKure Therapeutics | Initiated Coverage | $5.00 | $33.00 | Outperform | N/A |
| 12/4/2024 | RLMD Relmada Therapeutics | Reiterated Rating | $0.00 | $10.00 ➝ $1.00 | Outperform ➝ Market Perform | N/A |
| 12/4/2024 | RLAY Relay Therapeutics | Lower Price Target | $3.00 | $19.00 ➝ $18.00 | Outperform ➝ Outperform | N/A |
| 12/3/2024 | JANX Janux Therapeutics | Boost Price Target | $30.00 | $79.00 ➝ $91.00 | Outperform ➝ Outperform | N/A |
| 12/2/2024 | CLYM Climb Bio | Initiated Coverage | $1.00 | $10.00 | Outperform | N/A |
| 12/2/2024 | ELAN Elanco Animal Health | Initiated Coverage | $10.00 | $14.00 | Market Perform | N/A |
| 12/2/2024 | ZTS Zoetis | Initiated Coverage | $162.00 | $215.00 | Outperform | N/A |
| 12/2/2024 | IDXX IDEXX Laboratories | Initiated Coverage | $417.00 | $500.00 | Outperform | N/A |
| 11/27/2024 | AMGN Amgen | Lower Price Target | $307.00 | $349.00 ➝ $302.00 | | N/A |
| 11/22/2024 | JANX Janux Therapeutics | Initiated Coverage | $30.00 | $79.00 | Outperform | N/A |
| 11/22/2024 | ABBV AbbVie | Upgrade | $201.00 | $206.00 | Market Perform ➝ Outperform | N/A |
| 11/19/2024 | ACRS Aclaris Therapeutics | Upgrade | $2.00 | $2.00 ➝ $7.00 | Market Perform ➝ Outperform | N/A |
| 11/19/2024 | EHAB Enhabit | Reiterated Rating | $9.00 | $8.50 ➝ $8.00 | Market Perform ➝ Market Perform | N/A |
| 11/19/2024 | RCKT Rocket Pharmaceuticals | Lower Price Target | $8.00 | $46.00 ➝ $44.00 | Outperform ➝ Outperform | N/A |
| 11/19/2024 | ICLR ICON Public | Reiterated Rating | $178.00 | $270.00 ➝ $255.00 | Outperform ➝ Outperform | N/A |
| 11/19/2024 | IQV IQVIA | Reiterated Rating | $180.00 | $260.00 ➝ $248.00 | Outperform ➝ Outperform | N/A |
| 11/15/2024 | CMPX Compass Therapeutics | Downgrade | $2.00 | $5.00 ➝ $4.00 | Outperform ➝ Market Perform | N/A |
| 11/13/2024 | MASS 908 Devices | Reiterated Rating | $4.00 | $12.00 ➝ $4.00 | Outperform ➝ Market Perform | N/A |
| 11/13/2024 | LXEO Lexeo Therapeutics | Lower Price Target | $4.00 | $20.00 ➝ $19.00 | Outperform ➝ Outperform | N/A |
| 11/12/2024 | ARDT Ardent Health Partners | Boost Price Target | $13.00 | $23.00 ➝ $25.00 | Outperform ➝ Outperform | N/A |
| 11/12/2024 | NGNE Neurogene | Boost Price Target | $15.00 | $45.00 ➝ $72.00 | Outperform ➝ Outperform | N/A |
| 11/12/2024 | BMY Bristol-Myers Squibb | Upgrade | $59.00 | $55.00 ➝ $73.00 | Market Perform ➝ Outperform | N/A |
| 11/11/2024 | TECX Tectonic Therapeutic | Boost Price Target | $20.00 | $49.00 ➝ $69.00 | Outperform ➝ Outperform | N/A |
| 11/7/2024 | ZYME Zymeworks | Upgrade | $12.00 | $10.00 ➝ $25.00 | Market Perform ➝ Outperform | N/A |
| 11/7/2024 | XRAY DENTSPLY SIRONA | Downgrade | $15.00 | | Outperform ➝ Market Perform | N/A |
| 11/6/2024 | BEAM Beam Therapeutics | Upgrade | $22.00 | $27.00 ➝ $39.00 | Market Perform ➝ Outperform | N/A |
| 11/5/2024 | IDYA IDEAYA Biosciences | Downgrade | $17.00 | $41.00 ➝ $27.00 | Outperform ➝ Market Perform | Low |
| 11/4/2024 | ZURA Zura Bio | Initiated Coverage | $1.00 | $15.00 | Outperform | High |
| 10/31/2024 | NVST Envista | Upgrade | $17.00 | $16.00 ➝ $23.00 | Underperform ➝ Market Perform | High |
| 10/25/2024 | AQST Aquestive Therapeutics | Boost Price Target | $3.00 | $12.00 ➝ $13.00 | Outperform ➝ Outperform | Low |
| 10/25/2024 | DXCM DexCom | Lower Price Target | $72.00 | $90.00 ➝ $87.00 | Outperform ➝ Outperform | High |
| 10/25/2024 | ICLR ICON Public | Lower Price Target | $178.00 | $376.00 ➝ $270.00 | Outperform ➝ Outperform | High |
| 10/24/2024 | TENX Tenax Therapeutics | Initiated Coverage | $6.00 | $16.00 | Outperform | High |
| 10/21/2024 | GILD Gilead Sciences | Upgrade | $109.00 | $74.00 ➝ $96.00 | Market Perform ➝ Outperform | Low |
| 10/18/2024 | LXRX Lexicon Pharmaceuticals | Set Price Target | $0.00 | $6.00 | Outperform ➝ Outperform | Low |
| 10/18/2024 | TNYA Tenaya Therapeutics | Reiterated Rating | $1.00 | | Outperform ➝ Outperform | Low |
| 10/18/2024 | AMLX Amylyx Pharmaceuticals | Set Price Target | $4.00 | $4.00 | Market Perform ➝ Market Perform | High |
| 10/17/2024 | MASS 908 Devices | Lower Price Target | $4.00 | $15.00 ➝ $12.00 | Outperform ➝ Outperform | Medium |
| 10/17/2024 | GH Guardant Health | Lower Price Target | $46.00 | $60.00 ➝ $50.00 | Outperform ➝ Outperform | High |
| 10/17/2024 | BBIO BridgeBio Pharma | Lower Price Target | $36.00 | $47.00 ➝ $46.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | VCYT Veracyte | Boost Price Target | $31.00 | $35.00 ➝ $40.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | MIRM Mirum Pharmaceuticals | Boost Price Target | $46.00 | $47.00 ➝ $49.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | TWST Twist Bioscience | Boost Price Target | $42.00 | $45.00 ➝ $48.00 | Market Perform ➝ Market Perform | Medium |
| 10/17/2024 | RVTY Revvity | Boost Price Target | $107.00 | $130.00 ➝ $135.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | NTRA Natera | Boost Price Target | $151.00 | $140.00 ➝ $150.00 | Outperform ➝ Outperform | Medium |
| 10/17/2024 | ILMN Illumina | Boost Price Target | $84.00 | $160.00 ➝ $200.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | ISRG Intuitive Surgical | Boost Price Target | $510.00 | $489.00 ➝ $502.00 | | Low |
| 10/16/2024 | VYGR Voyager Therapeutics | Initiated Coverage | $4.00 | $15.00 | Outperform | High |
| 10/16/2024 | WVE Wave Life Sciences | Boost Price Target | $10.00 | $20.00 ➝ $22.00 | Outperform ➝ Outperform | High |
| 10/14/2024 | MNMD Mind Medicine (MindMed) | Initiated Coverage | $7.00 | $20.00 | Outperform | High |
| 10/14/2024 | STOK Stoke Therapeutics | Initiated Coverage | $7.00 | $18.00 | Outperform | High |
| 10/8/2024 | VINC Vincerx Pharma | Lower Price Target | $1.00 | $80.00 ➝ $40.00 | Outperform ➝ Outperform | High |
| 10/8/2024 | TVTX Travere Therapeutics | Reiterated Rating | $21.00 | $20.00 ➝ $20.00 | Outperform ➝ Outperform | Medium |
| 10/8/2024 | HOLX Hologic | Lower Price Target | $61.00 | $95.00 ➝ $90.00 | Outperform ➝ Outperform | Low |
| 10/7/2024 | COR Cencora | Lower Price Target | $270.00 | $277.00 ➝ $275.00 | Outperform ➝ Outperform | Low |
